
51 - 200 employees
Founded 2006
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
Biotechnology • Pharmaceuticals • Science
Precision BioSciences, Inc. is a clinical-stage biotechnology company developing in vivo and ex vivo genome editing and cell therapy medicines using its proprietary ARCUS nuclease technology. The company focuses on potentially curative treatments for hard-to-treat and rare genetic diseases (including chronic hepatitis B, Duchenne muscular dystrophy, and mitochondrial disorders) and allogeneic CAR T cell therapies for oncology. Precision BioSciences advances programs through preclinical and clinical trials, maintains collaborations and licensing agreements with biopharma partners, and pursues patent protection for its ARCUS platform and specific therapeutic candidates.
🔥 0 minutes ago
Clinical Science Liaison at Precision BioSciences managing clinical trial relationships for PBGENE-DMD. Interface with clinical sites and advocacy communities for effective trial support.